Episode 1: Observations About P2Y12 Inhibitor Transitions in Cangrelor Treated Patients by CAMEO: Lessons Learned about Cangrelor published on 2023-02-10T19:02:51Z In the first episode of the CAMEO podcast, principal investigator Jennifer Rymer and co-investigator Jeff Washam discuss their firsthand experiences with the drug cangrelor and introduce the CAMEO Registry. Tune in to learn more about their recent analysis of CAMEO data, which revealed major variations in clinical use of the drug. You can earn 0.5 CME credits for listening to this episode through the Duke One Link Continuing Education website. Visit https://ja.dh.duke.edu/ to create or login to your account and search for CAMEO in the “find a course” field. Follow the steps at https://duke.is/vy8w8 to register for a Duke OneLink account today. Jennifer Rymer, MD, MBA, is the John Bush Simpson Assistant Professor of Medicine at Duke University and Principal Investigator of the CAMEO registry. Dr. Rymer is an interventional cardiologist, and she is a faculty member at the Duke Clinical Research Institute. Jeffrey Washam, PharmD, FAHA, is a clinical pharmacist in the Cardiac Intensive Care Unit at Duke University Hospital, co-investigator of the CAMEO registry, and a consulting associate in the Duke Department of Medicine. Visit https://duke.is/rwd3w to view a transcript of this episode. Genre Science